T1	Participants 108 209	T1-2 glottic squamous cell carcinomas: results of a Korean Radiation Oncology Group (KROG-0201) study
T2	Participants 329 352	early glottic carcinoma
T3	Participants 375 442	Patients with T1-2 glottic carcinoma were eligible for the protocol
T4	Participants 453 556	282 patients were required, the study was closed prematurely due to poor accrual with only 156 patients
